Dermatology · Carbondale, IL
NPI
1124554209
Since 2017
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1400 Financial Park
Carbondale, IL, 62902
Phone (618) 351-9140
Groups this clinician bills Medicare through
Medicare paid, 2024
$377K
10,624 services
Medicare patients, 2024
1,437
Average age 73
Drug cost, 2024
$1.6M
2,221 prescriptions
Company payments, 2025
$53K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hal A Lewis was code 17003 (destruction skin lesion), 5,286 times for 760 patients. In total Hal A Lewis billed 10,624 services in 73 codes, and Medicare paid $377K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 5,286 | 760 | $4.55 | $24K |
| 17000 Destruction Skin Lesion | Office | 1,394 | 939 | $37.27 | $52K |
| 99214 Office E&M - Established | Office | 942 | 611 | $86.94 | $82K |
| 99213 Office E&M - Established | Office | 813 | 656 | $60.63 | $49K |
| 11102 Skin Biopsy | Office | 395 | 342 | $62.40 | $25K |
| 17110 Destruction Skin Lesion | Office | 311 | 277 | $73.38 | $23K |
| 99204 Office E&M - New | Office | 232 | 232 | $110.98 | $26K |
| 99203 Office E&M - New | Office | 226 | 226 | $74.16 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 194 | 150 | $12.29 | $2,385 |
| 11103 Skin Biopsy | Office | 163 | 88 | $36.50 | $5,949 |
| 17262 Destruction Skin Lesion | Office | 133 | 99 | $106.87 | $14K |
| 17004 Destruction Skin Lesion | Office | 56 | 44 | $110.07 | $6,164 |
| 17282 Destruction Skin Lesion | Office | 48 | 38 | $126.26 | $6,060 |
| 17272 Destruction Skin Lesion | Office | 48 | 38 | $115.98 | $5,567 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 35 | 18 | $0.69 | $24.26 |
By year: 2022 $271K for 5,785 services; 2023 $359K for 8,536 services; 2024 $377K for 10,624 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hal A Lewis prescribed most often to Medicare patients was Clobetasol Propionate, with 419 prescriptions and refills. In total Hal A Lewis wrote 2,221 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 419 | 441 | 209 | $20K |
| Fluorouracil Generic | 297 | 309 | 242 | $22K |
| Triamcinolone Acetonide Generic | 285 | 391 | 188 | $4,039 |
| Doxycycline Hyclate Generic | 126 | 141 | 71 | $2,072 |
| Hydrocortisone Generic | 95 | 119 | 62 | $1,152 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 88 | 91 | 46 | $1,656 |
| Ketoconazole Generic | 85 | 95 | 42 | $2,439 |
| Mupirocin Generic | 74 | 74 | 50 | $568 |
| Fluocinonide Generic | 63 | 84 | 42 | $3,086 |
| Clindamycin Phosphate Generic | 63 | 67 | 25 | $2,216 |
| Metronidazole Generic | 60 | 65 | 45 | $2,835 |
| Prednisone Generic | 40 | 41 | 24 | $191 |
| Valacyclovir Valacyclovir Hcl | 37 | 37 | 20 | $234 |
| Hydroxychloroquine Sulfate Generic | 36 | 60 | Under 11 | $1,558 |
| Taltz Autoinjector Ixekizumab | 35 | 35 | Under 11 | $231K |
Brand drugs: 232 claims; generic drugs: 1,989 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hal A Lewis $53K ($53K in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $32K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 30 | $32K |
| Abbvie Inc. ABBV | 44 | $20K |
| E.R. Squibb & Sons, L.L.C. BMY | 18 | $156 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $125 |
| Organon LLC OGN | 12 | $116 |
| Pfizer Inc. PFE | 4 | $71.63 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $59.15 |
| Genzyme Corporation SNY | 3 | $55.45 |
| Incyte Corporation INCY | 2 | $51.47 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $33.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.